论文部分内容阅读
倍他乐克(Betaloc)自1975年用于治疗高血压,近十年来对心血管疾病的治疗颇受重视.本文旨在探讨该药对中青年原发性高血压(EH)的降压效果及其对血浆内皮素(ET)的影响.一、对象:按WHO的诊断标准选择中青年EH26例,男16例,女10例,年龄30～55(平均 46岁),病程在 6～12年,其中Ⅰ期8例,Ⅱ期16例,Ⅲ期2例.所有病例均详细询问病史并做全面体检,查眼底、胸片、心电图、超声心动图、血脂、血糖、肝肾功能、尿常规等,
Betaloc has been used for the treatment of hypertension since 1975, and has been paid much attention to the treatment of cardiovascular disease in recent ten years.This paper aims to investigate the antihypertensive effect of this medicine on middle-aged and young people with essential hypertension (EH) Objective: To select 26 young and middle-aged EH patients according to WHO diagnostic criteria, including 16 males and 10 females, aged from 30 to 55 (average 46 years old), with a course of 6 to 12 Year, of which 8 cases of stage Ⅰ, 16 cases of stage Ⅱ, 2 cases of stage Ⅲ. All cases were asked in detail about the history and do a comprehensive physical examination, check the fundus, chest X-ray, electrocardiogram, echocardiography, blood lipids, blood glucose, liver and kidney function, Routine, etc.,